621
Views
23
CrossRef citations to date
0
Altmetric
Review Article

Coffee Drinking and the Risk of Endometrial Cancer: An Updated Meta-Analysis of Observational Studies

, , , ORCID Icon, , & show all
Pages 513-528 | Received 01 Sep 2017, Accepted 30 Jan 2018, Published online: 30 Apr 2018

References

  • Bohn SK, Blomhoff R, and Paur I: Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res 58(5), 915–930, 2014. doi:10.1002/mnfr.201300526.
  • Renehan AG, Roberts DL, and Dive C: Obesity and cancer: pathophysiological and biological mechanisms. Arch Physiol Biochem 114(1), 71–83, 2008. doi:10.1080/13813450801954303.
  • Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al.: Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol 17(7), 877–878, 2016. doi:10.1016/S1470-2045(16)30239-X.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, et al.: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5), E359–E386, 2015. doi:10.1002/ijc.29210.
  • Zhou Q, Luo ML, Li H, Li M, and Zhou JG. Coffee consumption and risk of endometrial cancer: A dose-response meta-analysis of prospective cohort studies. Sci Rep 5, 13410, 2015.
  • Bravi F, Scotti L, Bosetti C, Gallus S, Negri E, et al.: Coffee drinking and endometrial cancer risk: a metaanalysis of observational studies. Am J Obstet Gynecol 200(2), 130–135, 2009. doi:10.1016/j.ajog.2008.10.032.
  • Yang TO, Crowe F, Cairns BJ, Reeves GK, and Beral V: Tea and coffee and risk of endometrial cancer: cohort study and meta-analysis. Am J Clin Nutr 101(3), 570–578, 2015. doi:10.3945/ajcn.113.081836.
  • Je Y, and Giovannucci E: Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 131(7), 1700–1710, 2012. doi:10.1002/ijc.27408.
  • World Cancer Research Fund / American Institute for Cancer Research: Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: IARC, 2007, p. 300.
  • Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, et al.: Body fatness and cancer – viewpoint of the IARC working group. New Engl J Med 375(8), 794–798, 2016. doi:10.1056/NEJMsr1606602.
  • Dersimonian R, and Laird N: Metaanalysis in clinical-trials. Control Clin Trials 7(3), 177–188, 1986. doi:10.1016/0197-2456(86)90046-2.
  • Greenland S, and Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11), 1301–1309, 1992. doi:10.1093/oxfordjournals.aje.a116237.
  • Orsini N, Li R, Wolk A, Khudyakov P, and Spiegelman D: Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1), 66–73, 2012. doi:10.1093/aje/kwr265.
  • Orsini N, Bellocco R, and Greenland S: Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1), 40–57, 2006.
  • Royston P, and Parmar MK: Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 21(15), 2175–2197, 2002. doi:10.1002/sim.1203.
  • Orsini N: Multivariate dose-response meta-analysis: an update on glst. 2013. Available from: http://www.stata.com/meeting/nordic-and-baltic13/abstracts/materials/se13_orsini.pdf.
  • Higgins JP, Thompson SG, Deeks JJ, and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327(7414), 557–560, 2003. doi:10.1136/bmj.327.7414.557.
  • Peters JL, Sutton AJ, Jones DR, Abrams KR, and Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA 295(6), 676–680, 2006. doi:10.1001/jama.295.6.676.
  • Jacobsen BK, Bjelke E, Kvale G, and Heuch I: Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 76(5), 823–831, 1986.
  • Stensvold I, and Jacobsen BK: Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5), 401–408, 1994. doi:10.1007/BF01694753.
  • Levi F, Franceschi S, Negri E, and La Vecchia C: Dietary factors and the risk of endometrial cancer. Cancer 71(11), 3575–3581, 1993. doi:10.1002/1097-0142(19930601)71:11<3575::AID-CNCR2820711119>3.0.CO;2-0.
  • Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, et al.: Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 57(22), 5077–5085, 1997.
  • Bravi F, Scotti L, Bosetti C, Zucchetto A, Talamini R, et al.: Food groups and endometrial cancer risk: a case-control study from Italy. Am J Obstet Gynecol 200(3), 293e1–293e7, 2009. doi:10.1016/j.ajog.2008.09.015.
  • Petridou E, Kedikoglou S, Koukoulomatis P, Dessypris N, and Trichopoulos D: Diet in relation to endometrial cancer risk: a case-control study in Greece. Nutr Cancer 44(1), 16–22, 2002. doi:10.1207/S15327914NC441_3.
  • Petridou E, Koukoulomatis P, Dessypris N, Karalis D, Michalas S, et al.: Why is endometrial cancer less common in Greece than in other European Union countries? Eur J Cancer Prev 11(5), 427–432, 2002. doi:10.1097/00008469-200210000-00004.
  • Merritt MA, Tzoulaki I, Tworoger SS, De Vivo I, Hankinson SE, et al.: Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSII. Cancer Epidemiol Biomarkers Prev 24(2), 466–471, 2015. doi:10.1158/1055-9965.EPI-14-0970.
  • Je Y, Hankinson SE, Tworoger SS, De Vivo I, and Giovannucci E: A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev 20(12), 2487–2495, 2011. doi:10.1158/1055-9965.EPI-11-0766.
  • Gavrilyuk O, Braaten T, Skeie G, Weiderpass E, Dumeaux V, et al.: High coffee consumption and different brewing methods in relation to postmenopausal endometrial cancer risk in the Norwegian women and cancer study: a population-based prospective study. BMC Womens Health 14, 48, 2014. doi:10.1186/1472-6874-14-48.
  • Weiderpass E, Sandin S, Lof M, Oh JK, Inoue M, et al.: Endometrial cancer in relation to coffee, tea, and caffeine consumption: a prospective cohort study among middle-aged women in Sweden. Nutr Cancer 66(7), 1132–1143, 2014. doi:10.1080/01635581.2014.948214.
  • Uccella S, Mariani A, Wang AH, Vierkant RA, Cliby WA, et al.: Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer. Br J Cancer 109(7), 1908–1913, 2013. doi:10.1038/bjc.2013.540.
  • Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, et al.: Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer 113(5), 809–816, 2015. doi:10.1038/bjc.2015.276.
  • Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Kurahashi N, et al.: Coffee consumption and risk of endometrial cancer: a prospective study in Japan. Int J Cancer 123(10), 2406–2410, 2008. doi:10.1002/ijc.23760.
  • Nilsson LM, Johansson I, Lenner P, Lindahl B, and Van Guelpen B: Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer Causes Control 21(10), 1533–1544, 2010. doi:10.1007/s10552-010-9582-x.
  • Gunter MJ, Schaub JA, Xue X, Freedman ND, Gaudet MM, et al.: A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 131(4), E530–E536, 2012. doi:10.1002/ijc.26482.
  • Friberg E, Orsini N, Mantzoros CS, and Wolk A: Coffee drinking and risk of endometrial cancer–a population-based cohort study. Int J Cancer 125(10), 2413–2417, 2009. doi:10.1002/ijc.24543.
  • Giri A, Sturgeon SR, Luisi N, Bertone-Johnson E, Balasubramanian R, et al.: Caffeinated coffee, decaffeinated coffee and endometrial cancer risk: a prospective cohort study among US postmenopausal women. Nutrients 3(11), 937–950, 2011. doi:10.3390/nu3110937.
  • Bandera EV, Williams-King MG, Sima C, Bayuga-Miller S, Pulick K, et al.: Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey. Cancer Causes Control 21(9), 1467–1473, 2010. doi:10.1007/s10552-010-9575-9.
  • McCann SE, Yeh M, Rodabaugh K, and Moysich KB: Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk. Int J Cancer 124(7), 1650–1653, 2009. doi:10.1002/ijc.24125.
  • Terry P, Vainio H, Wolk A, and Weiderpass E: Dietary factors in relation to endometrial cancer: a nationwide case-control study in Sweden. Nutr Cancer 42(1), 25–32, 2002. doi:10.1207/S15327914NC421_4.
  • Jain MG, Howe GR, and Rohan TE: Nutritional factors and endometrial cancer in Ontario, Canada. Cancer Control 7(3), 288–296, 2000. doi:10.1177/107327480000700312.
  • Koizumi T, Nakaya N, Okamura C, Sato Y, Shimazu T, et al.: Case-control study of coffee consumption and the risk of endometrial endometrioid adenocarcinoma. Eur J Cancer Prev 17(4), 358–363, 2008. doi:10.1097/CEJ.0b013e3282f0c02c.
  • Hirose K, Niwa Y, Wakai K, Matsuo K, Nakanishi T, et al.: Coffee consumption and the risk of endometrial cancer: Evidence from a case-control study of female hormone-related cancers in Japan. Cancer Sci 98(3), 411–415, 2007. doi:10.1111/j.1349-7006.2007.00391.x.
  • Kalandidi A, Tzonou A, Lipworth L, Gamatsi I, Filippa D, et al.: A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. Oncology 53(5), 354–359, 1996. doi:10.1159/000227587.
  • Ding M, Bhupathiraju SN, Chen M, van Dam RM, and Hu FB: Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37(2), 569–586, 2014. doi:10.2337/dc13-1203.
  • Friberg E, Orsini N, Mantzoros CS, and Wolk A: Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50(7), 1365–1374, 2007. doi:10.1007/s00125-007-0681-5.
  • Wu T, Willett WC, Hankinson SE, and Giovannucci E: Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28(6), 1390–1396, 2005. doi:10.2337/diacare.28.6.1390.
  • Cust AE, Allen NE, Rinaldi S, Dossus L, Friedenreich C, et al.: Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 120(12), 2656–2664, 2007. doi:10.1002/ijc.22578.
  • Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, et al.: Prediagnostic levels of C-peptide, IGF-I, IGFBP −1, −2 and −3 and risk of endometrial cancer. Int J Cancer 108(2), 262–268, 2004. doi:10.1002/ijc.11544.
  • Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, and Tworoger SS: Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115(12), 2765–2774, 2009. doi:10.1002/cncr.24328.
  • Ferrini RL, and BarrettConnor E: Caffeine intake and endogenous sex steroid levels in postmenopausal women – The Rancho Bernardo Study. Am J Epidemiol 144(7), 642–644, 1996. doi:10.1093/oxfordjournals.aje.a008975.
  • Nagata C, Kabuto M, and Shimizu H: Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 30(1), 21–24, 1998. doi:10.1080/01635589809514635.
  • London S, Willett W, Longcope C, and McKinlay S: Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 53(1), 166–171, 1991. doi:10.1093/ajcn/53.1.166.
  • Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, et al.: Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 15(2), 485–497, 2008. doi:10.1677/ERC-07-0064.
  • Lee KA, Chae JI, and Shim JH: Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma. J Biomed Sci 19, 2012.
  • Cardenas C, Quesada AR, and Medina MA: Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PLoS One 6(8), e23407, 2011. doi:10.1371/journal.pone.0023407.
  • Cardenas C, Quesada AR, and Medina MA: Insights on the antitumor effects of kahweol on human breast cancer: decreased survival and increased production of reactive oxygen species and cytotoxicity. Biochem Biophys Res Commun 447(3), 452–458, 2014. doi:10.1016/j.bbrc.2014.04.026.
  • Higgins LG, Cavin C, Itoh K, Yamamoto M, and Hayes JD: Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein. Toxicol Appl Pharmacol 226(3), 328–337, 2008. doi:10.1016/j.taap.2007.09.018.
  • Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, et al.: Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31(3), 504–507, 2008. doi:10.2337/dc07-1952.
  • Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, et al.: Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2, e33, 2012. doi:10.1038/nutd.2012.6.
  • Dalamaga M, Diakopoulos KN, and Mantzoros CS: The role of adiponectin in cancer: a review of current evidence. Endocr Rev 33(4), 547–594, 2012. doi:10.1210/er.2011-1015.
  • Li ZJ, Yang XL, Yao Y, Han WQ, and Li BO: Circulating adiponectin levels and risk of endometrial cancer: Systematic review and meta-analysis. Exp Ther Med 11(6), 2305–2313, 2016. doi:10.3892/etm.2016.3251.
  • Shearer J, Farah A, de Paulis T, Bracy DP, Pencek RR, et al.: Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 133(11), 3529–3532, 2003. doi:10.1093/jn/133.11.3529.
  • Terrin N, Schmid CH, Lau J, and Olkin I: Adjusting for publication bias in the presence of heterogeneity. Stat Med 22(13), 2113–2126, 2003. doi:10.1002/sim.1461.
  • Higgins JPT, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011; Chapter 10.4.3.1. Available from www.handbook.cochrane.org.
  • Yu X, Bao Z, Zou J, and Dong J: Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 11, 96, 2011. doi:10.1186/1471-2407-11-96.
  • Wang A, Wang S, Zhu C, Huang H, Wu L, et al.: Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci Rep 6, 33711, 2016. doi:10.1038/srep33711.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.